Despite proven effectiveness of medications in preventing stone recurrence, compliance with pharmacotherapy is often poor due to cost, side effects and impact on lifestyle. We sought to compare the risk of stone recurrence between patients managed with conservative therapy versus pharmacotherapy controlling for aggressiveness of stone disease.